Newborn Screening Ind. Market New Research on Growth 2018| With Top Company’s: DiaDx, Roche, Myriad Genetics, Qiagen, Exosome Sciences, Inc., Inivata Limited, and Others .

The Knowledge of Market Definition, Classifications, Applications and Market trends can make a huge a difference in the Newborn Screening Market. The market is changing because of the key players and brands which make moves like developments, product launches, joint ventures, merges and accusations that in turns changes the view of the global face of Health Care Industry.

This report contains all the market drivers and restrains that are derived using SWOT analysis, while all the way explaining what the market definition, classifications, applications and market trends are. The report also has the CAGR values for the historic years 2016 base year 2017 and forecast for the years 2018-2025.

Get Free Sample of Research Report: http://databridgemarketresearch.com/request-a-sample/?dbmr=global-newborn-screening-market

Global Newborn Screening Market is estimated to reach USD 2,258.12 million by 2025 from USD 1,008.64 million in 2017, at a CAGR of 10.7% in the forecast period 2018 to 2025. The new market report contains data for historic years 2016, the base year of calculation is 2017 and the forecast period is 2018 to 2025.

• According to American Academy of Paediatrics (AAP), in 2018, an article published that stated that each year 4.1 million new-borns are screened for congenital disorders in the U.S. Out of which four thousands infants are detected with disorder and it is assessed that another 1,000 infants were undetected with conditions.

• According to National Institute of Child Health and Human Development (NICHD), about 4 million infants are born each year in the U.S. and it is
reported that 99.9% or higher number of infants were screened.

• According to World Health Organization (WHO), neonatal mortality has been decreased. This is because people have started choosing newborn screening. This is because it detects the disorder effectively as compared to other practices.

Newborn Screening Market Major Players:

Some of the prominent players operating in this market are-
• PerkinElmer Inc.,
• Trivitron Healthcare,
• Interacoustics A/S ,
• Bio-Rad Laboratories, Inc.,
• Natus Medical Incorporated,
• Masimo,
• Medtronic,
• Intelligent Hearing Systems,
• Interacoustics A/S,
• Otodynamics Ltd,
• Vivosonic Inc.,
• ZenTech S.A.,
• AB Sciex, Welch Allyn,
• Baebies, Inc.

RISING PREVALENCE OF NEWBORN SCREENING:

Newborn screening is the testing used in the diagnoses of harmful and fatal disorders in newborns, which can adversely affect their long term health. Early detection and diagnosis of disorders will reduce the death along with the diseases and associated disabilities.
Currently, this screening tests around thirty metabolic and genetic diseases. Some of them are phenylketonuria (PKU), congenital hypothyroidism (CH), galactosemia (GAL), and sickle cell disease. The screening program offers appropriate diagnosis, treatment, and ongoing evaluation.

Table Of Contents:

• 1. Introduction
• 2. Market Segmentation
• 3. Market Overview
• 4. Executive Summary
• 5. Premium Insights
• 6. Global, By Component
• 7. Product Type
• 8. Delivery
• 9. Industry Type
• 10. Geography
• 10.1. Overview
• 10.2. North America
• 10.3. Europe
• 10.4. Asia-Pacific
• 10.5. South America
• 10.6. Middle East & Africa
• 11. Company Landscape
• 12. Company Profiles
• 13. Related Reports

Get Free TOC Of report@ https://databridgemarketresearch.com/toc/?dbmr=global-newborn-screening-market

Market Scope: Newborn Screening Market

• The global newborn screening market is segmented on the basis of test types into dried blood spot (DBS) test, critical congenital heart diseases (CCHD) test and hearing screen test. In 2018, dried blood spot segment is projected to dominate the market with a share of around 44.0%.

• The global newborn screening market is segmented on the basis of product type into instruments and reagents & assay kits. In 2018, the instruments segment is estimated to dominate market with a share of around 68.0%. The instruments are further sub-segmented into newborn disorder screening, newborn hearing screening, and pulse oximeter.

• The global newborn screening market is segmented on the basis of technologies into tandem mass spectrometry, hearing screen, pulse oximetry screening, immunoassays and enzymatic assays, electrophoresis and DNA-based assays. In 2018, tandem mass spectrometry segment is likely to dominate the market and it is expected to grow at the highest CAGR in the forecast period.

• The global newborn screening market is segmented on the basis of disease type into phenylketonuria, cystic fibrosis, sickle cell disease, newborn hearing loss, critical congenital heart diseases, maple syrup urine disease and others. In 2018, critical congenital heart diseases segment will dominate the market and is projected to reach 1,492.98 million by 2025.

• The global newborn screening market is divided on the basis of end user into hospitals, pediatric clinics, and clinics. In 2018, hospitals segment is expected to dominate market with a share of around 70% and is estimated to grow at the highest CAGR of 10.9%.

• Based on geography, the market is segmented into 5 geographical regions, North America, Europe, Asia-Pacific, South America and Middle East and Africa.

Key questions answered in the report:

• What will the market growth rate of Newborn Screening Market in 2025?
• What are the key factors driving the Global Newborn Screening Market?
• Who are the key manufacturers in Newborn Screening Market space?
• What are the market opportunities, market risk and market overview of the Research Newborn Screening Market?
• What are sales, revenue, and price analysis of top manufacturers of Newborn Screening Market?
• Who are the distributors, traders and dealers of Newborn Screening Market?
• What are the Core Materials Market opportunities and threats faced by the vendors in the Newborn Screening Industry?
• What are sales, revenue, and price analysis by types and applications Newborn Screening Market?
• What are sales, revenue, and price analysis by regions of Newborn Screening Industry?

Report Brief Focus On:

Global Newborn Screening Market By Test Type (Dried Blood Spot Test, Hearing Screen Test, Critical Congenital Heart Diseases Test), Product Type (Instruments, Reagents & Assay Kits), Technology (Tandem Mass Spectrometry, Hearing Screen Technology, Pulse Oximetry Screening Technology, Immunoassays And Enzymatic Assays, Electrophoresis, DNA-Based Assays), Diseases Type (Phenylketonuria, Cystic Fibrosis, Sickle Cell Disease, Newborn Hearing Loss, Critical Congenital Heart Diseases, Maple Syrup Urine Disease), End User (Hospital, Pediatric Clinics, Clinics), By Geography (North America, South America, Europe, Asia-Pacific, Middle East and Africa)- Industry Trends and Forecast to 2025

Note: If you have any special requirements, please let us know and we will offer you the report as you want.

Customization With Discount Available On This Report@ http://databridgemarketresearch.com/speak-to-analyst/?dbmr=global-newborn-screening-market

About Us
Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with an unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Contact:
Data Bridge Market Research
Tel: +1-888-387-281
Email: sopan.gedam@databridgemarketresearch.com

This release was published on openPR.